| Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases PJ Simner, S Miller, KC Carroll Clinical Infectious Diseases 66 (5), 778-788, 2018 | 575 | 2018 |
| Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection M Castanheira, PJ Simner, PA Bradford JAC-antimicrobial resistance 3 (3), dlab092, 2021 | 435 | 2021 |
| Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia PD Tamma, KE Goodman, AD Harris, T Tekle, A Roberts, A Taiwo, ... Clinical Infectious Diseases 64 (3), 257-264, 2017 | 385 | 2017 |
| Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among Enterobacteriaceae VM Pierce, PJ Simner, DR Lonsway, DE Roe-Carpenter, JK Johnson, ... Journal of clinical microbiology 55 (8), 2321-2333, 2017 | 384 | 2017 |
| Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006 GG Zhanel, M DeCorby, N Laing, B Weshnoweski, R Vashisht, F Tailor, ... Antimicrobial agents and chemotherapy 52 (4), 1430-1437, 2008 | 369 | 2008 |
| Phenotypic detection of carbapenemase-producing organisms from clinical isolates PD Tamma, PJ Simner Journal of clinical microbiology 56 (11), 10.1128/jcm. 01140-18, 2018 | 256 | 2018 |
| Can multidrug-resistant Candida auris be reliably identified in clinical microbiology laboratories? M Mizusawa, H Miller, R Green, R Lee, M Durante, R Perkins, C Hewitt, ... Journal of clinical microbiology 55 (2), 638-640, 2017 | 244 | 2017 |
| Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008) GG Zhanel, M DeCorby, H Adam, MR Mulvey, M McCracken, ... Antimicrobial agents and Chemotherapy 54 (11), 4684-4693, 2010 | 235 | 2010 |
| A primer on AmpC β-lactamases: necessary knowledge for an increasingly multidrug-resistant world PD Tamma, Y Doi, RA Bonomo, JK Johnson, PJ Simner, ... Clinical infectious diseases 69 (8), 1446-1455, 2019 | 216 | 2019 |
| Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase-and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian … AJ Denisuik, PRS Lagacé-Wiens, JD Pitout, MR Mulvey, PJ Simner, ... Journal of Antimicrobial Chemotherapy 68 (suppl_1), i57-i65, 2013 | 193 | 2013 |
| Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study JA Karlowsky, PRS Lagacé-Wiens, PJ Simner, MR DeCorby, HJ Adam, ... Antimicrobial agents and chemotherapy 55 (7), 3169-3175, 2011 | 183 | 2011 |
| Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing Gram-negative bacilli S Vasoo, SA Cunningham, PC Kohner, PJ Simner, JN Mandrekar, ... Journal of clinical microbiology 51 (9), 3097-3101, 2013 | 168 | 2013 |
| Multicenter evaluation of the Accelerate PhenoTest BC kit for rapid identification and phenotypic antimicrobial susceptibility testing using morphokinetic cellular analysis P Pancholi, KC Carroll, BW Buchan, RC Chan, N Dhiman, B Ford, ... Journal of clinical microbiology 56 (4), 10.1128/jcm. 01329-17, 2018 | 166 | 2018 |
| Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE) KE Goodman, PJ Simner, PD Tamma, AM Milstone Expert review of anti-infective therapy 14 (1), 95-108, 2016 | 150 | 2016 |
| Comparison of 11 phenotypic assays for accurate detection of carbapenemase-producing Enterobacteriaceae PD Tamma, BNA Opene, A Gluck, KK Chambers, KC Carroll, PJ Simner Journal of clinical microbiology 55 (4), 1046-1055, 2017 | 138 | 2017 |
| Carbapenem-resistant non-glucose-fermenting gram-negative bacilli: the missing piece to the puzzle TJ Gniadek, KC Carroll, PJ Simner Journal of clinical microbiology 54 (7), 1700-1710, 2016 | 136 | 2016 |
| Metagenomic next-generation sequencing of nasopharyngeal specimens collected from confirmed and suspect COVID-19 patients HH Mostafa, JA Fissel, B Fanelli, Y Bergman, V Gniazdowski, M Dadlani, ... MBio 11 (6), 10.1128/mbio. 01969-20, 2020 | 129 | 2020 |
| Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays K Uhteg, J Jarrett, M Richards, C Howard, E Morehead, M Geahr, L Gluck, ... Journal of Clinical Virology 127, 104384, 2020 | 128 | 2020 |
| Activity of NXL104 in combination with β-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum β … PRS Lagacé-Wiens, F Tailor, P Simner, M DeCorby, JA Karlowsky, ... Antimicrobial agents and chemotherapy 55 (5), 2434-2437, 2011 | 122* | 2011 |
| Cefiderocol antimicrobial susceptibility testing considerations: the Achilles' heel of the Trojan horse? PJ Simner, R Patel Journal of clinical microbiology 59 (1), 10.1128/jcm. 00951-20, 2020 | 111 | 2020 |
